SpiroChem is pleased to announce its participation in the Peptide Therapeutics Forum 2026 taking place on June 4–5, 2026 at the Biozentrum in Basel, Switzerland.

Over the last decade, the meeting has become one of the leading interdisciplinary conferences on bioactive peptides. Academic and industrial groups present state-of-the-art research ranging from fundamental peptide science to pre-clinical and clinical drug candidates at all stages of development.

The forum brings together participants from universities, research institutes, the global pharmaceutical industry, regulatory authorities and CDMOs, offering a unique platform to exchange ideas, spark collaborations and shape the future of peptide therapeutics.

Meet our representative on-site: Thomas Fessard, PhD – Chief Executive Officer

Thomas Fessard, PhD, will give a talk on June 4 at 2:00 PM: “From Peptides to Drugs: Expanding the Frontiers of Medicinal Chemistry”

Join us in Basel to connect with our team and discuss how SpiroChem’s expertise in peptide and medicinal chemistry can support your programs, from hit identification and lead optimization to the design of innovative chemical matter.

We look forward to engaging with the peptide therapeutics community and exploring new opportunities for collaboration.